News from the partners

MRC/UVRI and LSHTM Uganda Research Unit

Featured
PrEPVacc meets the media in Masaka
PrEPVacc meets the media in Masaka
FAQs for PrEPVacc's vaccine result
FAQs for PrEPVacc's vaccine result
Media coverage of PrEPVacc's July 2024 vaccine result announcement
Media
Media coverage of PrEPVacc's July 2024 vaccine result announcement
Media
Media
News Release: HIV vaccines tested in PrEPVacc fail to reduce infections
Research
News Release: HIV vaccines tested in PrEPVacc fail to reduce infections
Research
Research
AIDS 2024: “I am not sick, why should I swallow daily pills?”: non-uptake of, and adherence to daily oral pre-exposure prophylaxis among adults at high-risk of HIV in Masaka, Uganda
Research
AIDS 2024: “I am not sick, why should I swallow daily pills?”: non-uptake of, and adherence to daily oral pre-exposure prophylaxis among adults at high-risk of HIV in Masaka, Uganda
Research
Research
AIDS 2024: Knowledge and experiences of participating in an HIV vaccine efficacy trial with second randomization to oral pre-exposure prophylaxis in South Africa, Tanzania, and Uganda
Research
AIDS 2024: Knowledge and experiences of participating in an HIV vaccine efficacy trial with second randomization to oral pre-exposure prophylaxis in South Africa, Tanzania, and Uganda
Research
Research
AIDS 2024: Disclosing of Participation in an HIV Vaccine Trial in Southwestern Uganda – the effect on participant engagement
Research
AIDS 2024: Disclosing of Participation in an HIV Vaccine Trial in Southwestern Uganda – the effect on participant engagement
Research
Research
AVAC briefing on PrEPVacc: An in-depth look at the trial, and what’s next
AVAC briefing on PrEPVacc: An in-depth look at the trial, and what’s next
News Release: Experimental HIV vaccine regimens likely to be ineffective in preventing HIV acquisition, PrEPVacc study reports
News Release: Experimental HIV vaccine regimens likely to be ineffective in preventing HIV acquisition, PrEPVacc study reports
STAT: 'Can the world still invent an HIV vaccine? Progress in one area creates new problem'
Media
STAT: 'Can the world still invent an HIV vaccine? Progress in one area creates new problem'
Media
Media

Muhimbili University of Health and Allied Sciences

National Institute for Medical Research - Mbeya Medical Research Centre

Instituto Nacional de Saúde - Moçambique

South African Medical Research Council

Featured
PrEPVacc Vaccine Results Dissemination at SAMRC Verulam: A Step Towards Hope
PrEPVacc Vaccine Results Dissemination at SAMRC Verulam: A Step Towards Hope
FAQs for PrEPVacc's vaccine result
FAQs for PrEPVacc's vaccine result
Media coverage of PrEPVacc's July 2024 vaccine result announcement
Media
Media coverage of PrEPVacc's July 2024 vaccine result announcement
Media
Media
News Release: HIV vaccines tested in PrEPVacc fail to reduce infections
Research
News Release: HIV vaccines tested in PrEPVacc fail to reduce infections
Research
Research
AIDS 2024: Knowledge and experiences of participating in an HIV vaccine efficacy trial with second randomization to oral pre-exposure prophylaxis in South Africa, Tanzania, and Uganda
Research
AIDS 2024: Knowledge and experiences of participating in an HIV vaccine efficacy trial with second randomization to oral pre-exposure prophylaxis in South Africa, Tanzania, and Uganda
Research
Research
AIDS 2024: HIV risk perception, trust and PrEP adherence among participants in an HIV prevention trial: a qualitative longitudinal study, South Africa
Research
AIDS 2024: HIV risk perception, trust and PrEP adherence among participants in an HIV prevention trial: a qualitative longitudinal study, South Africa
Research
Research
AVAC briefing on PrEPVacc: An in-depth look at the trial, and what’s next
AVAC briefing on PrEPVacc: An in-depth look at the trial, and what’s next
News Release: Experimental HIV vaccine regimens likely to be ineffective in preventing HIV acquisition, PrEPVacc study reports
News Release: Experimental HIV vaccine regimens likely to be ineffective in preventing HIV acquisition, PrEPVacc study reports
CNN reports on ‘the last roll of the dice’ for an HIV vaccine this decade
Media
CNN reports on ‘the last roll of the dice’ for an HIV vaccine this decade
Media
Media
News Release: African-led PrEPVacc HIV prevention study completes its enrolment
News Release: African-led PrEPVacc HIV prevention study completes its enrolment
Video to help inform PrEPVacc participants posted online
Video to help inform PrEPVacc participants posted online
Examining oral pre-exposure prophylaxis (PrEP) literacy among participants in an HIV vaccine trial preparedness cohort study
Research
Examining oral pre-exposure prophylaxis (PrEP) literacy among participants in an HIV vaccine trial preparedness cohort study
Research
Research
SAMRC PrEPVacc HIV Prevention Vaccine clinical trial in full swing
SAMRC PrEPVacc HIV Prevention Vaccine clinical trial in full swing
PrEPVacc featured in JIAS articles in Nov 2021
PrEPVacc featured in JIAS articles in Nov 2021
First enrolments to PrEPVacc clinical trial at SAMRC in Durban
First enrolments to PrEPVacc clinical trial at SAMRC in Durban
PrEPVacc welcomes results of HPTN 084 injectable PrEP study
PrEPVacc welcomes results of HPTN 084 injectable PrEP study
Leaflet for PrEPVacc participants published
Leaflet for PrEPVacc participants published
GPP training for PrEPVacc partners: our experience and lessons
GPP training for PrEPVacc partners: our experience and lessons
Tribute to Gita Ramjee
Tribute to Gita Ramjee
Cape Argus reports on PrEPVacc study application
Media
Cape Argus reports on PrEPVacc study application
Media
Media
SAMRC Durban research team members participate in a Gender Based Violence Workshop
SAMRC Durban research team members participate in a Gender Based Violence Workshop
SAMRC and HPRU engage at the SAAIDS 2019 Community village
SAMRC and HPRU engage at the SAAIDS 2019 Community village